Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,710 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,126
Recruiting: 10,896
Ph III recruiting: 1,279
Growth YoY: +12.3%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,169)

clinicaltrialsPublishedShowing 3,851–3,900 of 4,603 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06619743	HPV Infection and Vaginal Microecology in Immunosuppressed Women	not yet recruiting	—	10,000	Lan ZhuOTHER	0	Oct 1, 2024	clinicaltrials
NCT06619886	TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor	not yet recruiting	Early Phase 1	9	Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER	1	Oct 1, 2024	clinicaltrials